SciSparc Ltd. - Ordinary Shares (SPRC)
0.3650
+0.0207 (6.01%)
NASDAQ · Last Trade: May 12th, 3:29 PM EDT
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · May 5, 2025
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.
Via Chartmill · May 5, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via Chartmill · May 5, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · May 5, 2025
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · May 5, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via Chartmill · May 5, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · March 11, 2025

Via Benzinga · March 11, 2025

Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via Chartmill · March 10, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 10, 2025

SciSparc Ltd (NASDAQ:SPRC) shares are ripping higher Monday after the company announced that its collaboration with Clearmind Medicine Inc (NASDAQ:CMND) led to a patent application for psychedelic therapy targeting cocaine addiction.
Via Benzinga · March 10, 2025

Via Benzinga · January 6, 2025

SciSparc teams up with Clearmind Medicine on innovative therapies for binge behaviors and secures FDA approval for a Tourette Syndrome Phase 2b trial.
Via Benzinga · January 6, 2025

Via Benzinga · December 26, 2024

SciSparc Ltd. shares are soaring after its merger-bound AutoMax Motors received its first shipment of JAC vehicles. The shipment positions AutoMax to begin marketing and sales activities for JAC Motors vehicles across Israel.
Via Benzinga · December 26, 2024

Via Benzinga · December 26, 2024

SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon.
Via Benzinga · September 30, 2024

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
Via Benzinga · September 17, 2024

Via Benzinga · September 17, 2024